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Possible Production of  
Genome-Edited Animals Using 
Gene-Engineered Sperm
Masahiro Sato and Shingo Nakamura
Abstract
CRISPR/Cas9 is widely used for genome editing in a variety of organisms, 
including mammals, fishes, and plants. In mammals, zygotes are considered an 
appropriate target for gene delivery of CRISPR/Cas9 components [Cas9 endonucle-
ase and a single-guide (sgRNA)] via microinjection or in vitro electroporation. 
However, these approaches require ex vivo handling of zygotes, which is necessary 
for egg transfer to recipient females to allow the treated zygotes to develop full-
term. These procedures are often laborious, time-consuming, and use numerous 
mice. In our previous experiments, the plasmid DNA encapsulated by liposomal 
reagent introduced into the internal portion of a testis can be transferred to the 
mature sperm present in the epididymal ducts, and is finally transferred to oocytes 
via fertilization. Although it was not integrated into their genome, this approach 
would be useful for creating genome-edited animals, since CRISPR/Cas9 can be 
performed by transient interaction of Cas9 and sgRNA, whereby chromosomal 
integration of the CRISPR components is not a prerequisite. Here, we will review 
past achievements concerning in vivo transfection of immature/mature sperm and 
present experimental proposals for possible genome editing via gene-engineered 
sperm based on recent findings.
Keywords: sperm, CRISPR/Cas9, guide RNA, testis-mediated gene transfer,  
in vivo transfection, genome editing, vas deferens, epididymis, artificial insemination, 
intratesticular injection
1. Introduction
Transgenesis is a method to induce genetic change in an organism by deliver-
ing exogenous DNA (also called transgenes) to early embryos (i.e., zygotes), and 
is now considered an important technique to examine gene function in vivo and 
for creating animal models of human disease [1, 2]. In 1980, Gordon et al. [3] first 
demonstrated that microinjection of purified DNA fragments into the pronuclei 
of zygotes led to the production of mice carrying the transgenes, which are gener-
ally referred to as transgenic (Tg) or genetically modified (GM) mice. When the 
injected transgenes are successfully integrated into the host chromosomes of the 
zygotes, they are transmitted to the next generation through mating with normal 
mice in a Mendelian ratio, and gene expression derived from the integrated trans-
genes will occur in the Tg offspring depending on the property of the promoter 
used. For the production of Tg animals through zygote microinjection, several steps 
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are required for the “ex vivo handling of embryos,” including: collection of zygotes, 
DNA microinjection using an expensive micromanipulator, temporal incubation of 
the injected zygotes, and egg transfer (ET) to the oviducts of the pseudo-pregnant 
females to allow full-term development of the injected eggs [4, 5]. Furthermore, 
all of this requires highly specialized and skilled personnel for the preparation of 
pseudo-pregnant females and vasectomized males, which is time-consuming and 
tedious, and requires a large number of mice.
Since 1980, several methods for bypassing microinjection-based transgenesis 
have been provided, which include infection of zygotes with viral vectors like a 
retrovirus [6, 7], embryonic stem (ES) cell-based gene transfer [8–10], transgenesis 
via somatic cell nuclear transfer [11–13], and intracytoplasmic sperm injection 
(ICSI) using sperm associated with the transgene (TransICSI) [14, 15]. All of these 
methods deal with zygotes and require ex vivo handling of embryos, although a 
micromanipulator system is not used in almost the cases.
Genome-editing via Oviductal Nucleic Acids Delivery (GONAD) is a recently 
developed method for creating GM mice and rats without ex vivo handling of 
embryos [16–21]. It can be simply performed by injecting a solution containing 
nucleic acids into the oviductal lumen of pregnant females at zygote to two-cell 
stages and subsequent in vivo electroporation (EP) to enhance DNA uptake by early 
embryos in situ. In this case, there is no need for the large number of mice that is 
normally required for the traditional microinjection-based transgenesis: only four 
to five pregnant females are required for modifying an endogenous gene [18]. Thus, 
creation of GM animals is simplified with the development of GONAD, but an 
expensive apparatus electroporator is still required for the technique.
In 1989, Lavitrano et al. [22] reported the simplest, convenient, and cost-effective 
method to create GM animals, which was called sperm-mediated gene transfer 
(SMGT), where isolated sperm were incubated in the presence of naked plasmid DNA 
for a short period and these DNA-associated sperm were subjected to in vitro fertiliza-
tion (IVF) with normal oocytes. The resulting progeny are later judged as those carry-
ing the exogenous DNA in their genome. Since the report, there has been controversy 
over its reproducibility among researchers [23–25]. However, several recent improve-
ments were made on this SMGT system by several researchers who employed reagents 
capable of enhancing gene delivery towards isolated sperm [26–28]. For example, 
Shen et al. [29] incubated mouse sperm in a solution containing 3% dimethyl sulfoxide 
(DMSO) and plasmid DNA for 10–15 min at 4°C prior to IVF. Embryos (42%; 25/60) 
obtained from this experiment showed bright enhanced green fluorescent protein 
(EGFP)-derived fluorescence. Furthermore, Kim et al. [30] reported that nanopar-
ticles, such as magnetic nanoparticles, can be a vehicle for delivering exogenous 
DNA to sperm from various animals such as boar. They incubated boar sperm in the 
presence of 0.5% (v/v) of magnetic nanoparticles (MNPs) and plasmid DNA coding 
for green fluorescent protein (GFP) on the magnetic field for 90 min, and the magne-
tofected sperm were subjected to IVF with normal oocytes. As a result, they obtained 
fertilized eggs expressing GFP. Unfortunately, for further development of IVF-derived 
embryos, it still required ET towards recipient females, which is laborious and requires 
specialized skill. Notably, it is possible to perform artificial insemination (AI) using in 
vitro-transfected sperm, which can be simply done by injecting those sperm into the 
uterine horn or lumen of the oviducts of recipient females showing oocyte ovulation. 
This method, called “SMGT-based AI” (SMGT-AI), has already been performed by 
several laboratories and will be discussed in more detail in the last part of this paper.
Testis-mediated gene transfer (TMGT) is the in vivo version of SMGT, in which 
sperm is transfected in vivo. This technology was first developed by Sato et al. [31], 
who performed intratesticular injection of calcium phosphate-precipitated plasmid 
DNA using a glass micropipette in mice. The injected exogenous DNA is transferred 
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to epididymal sperm or spermatogenic cells within a seminiferous tubule (ST) of the 
testis, and those transfected sperm will transmit it to an oocyte through fertiliza-
tion (Figure 1). They could detect the injected DNA in isolates of sperm from the 
epididymis and from the uteri of females mated with the injected males, but the 
DNA could not be detected in embryos [31]. In contrast with SMGT, TMGT does 
not require ex vivo handling of embryos such as collection of oocytes, IVF and ET. In 
this context, TMGT appears to be more convenient and simpler than SMGT for the 
purpose of GM animal production. Since the report of Sato et al. [31], several in vivo 
gene delivery approaches targeted to male reproductive systems have been reported: 
gene delivery to spermatogenic cells by intratubular injection of STs (ST-mediated gene 
transfer, STGT) (Figure 2a), to epididymal sperm present in the epididymal ducts 
(epididymis-mediated gene transfer, EpiGT) (Figure 2b), and to sperm present in 
the vas deferens (vas deferens-mediated gene transfer, VDGT) (Figure 2c).
Based on this background, the previous terminology TMGT appears to be now 
recognized as “direct in vivo gene delivery approach towards male reproductive 
system.” In this context, it may be better to re-name TMGT as “intratesticular 
injection-based gene transfer” (IIGT), which involves direct injection of genetic 
materials into the interstitial space of a testis. Thus, IIGT, STGT, EpiGT and VDGT 
can be considered as TMGT-related experiments. In Table 1, a summary of previ-
ous studies on TMGT-related experiments is listed. Furthermore, there are several 
excellent papers reviewing the SMGT/TMGT-related studies [28, 90–93], which 
provide a helpful survey of this field.
Figure 1. 
IIGT in mice. To perform IIGT, at least three different ways to inject a DNA-containing solution into the testis 
have been employed. The first way (shown in a) is to perform IIGT towards a testis (that is exposed outside 
after surgery) under anesthesia [31, 32]. The second way (shown in b) is to perform IIGT through insertion of 
a needle via scrotum under anesthesia [33]. The third way (shown in c) is to insert a needle at three times to 
different sites [34]. In these latter two cases, no surgery is required. Three to five days after IIGT, the IIGT-
treated males are subjected to mating with normal estrous females. The in vivo transfected sperm may fertilize 
ovulated oocytes, leading to creation of offspring carrying the introduced exogenous DNA.
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice Plasmid/calcium phosphate The exogenous DNA was 
detectable in the sperm 
isolated from caput and cauda 
epididymides as early as 6 h after 
IIGT and in the ejaculated sperm 
from the female uteri, but not in 
1-cell eggs
[31]
IIGT Mice Plasmid/liposome/IIGT 3 
times at 4-day intervals
Eighty percent of blastocysts 
expressed lacZ from the exogenous 
DNA, suggesting successful 
transmission of the exogenous 
DNA to F0 offspring
[34]
IIGT Rats Adenovirus Leydig cells expressed the 
transgene
[35]
IIGT Mice Plasmid/EP Some spermatogenic-like cells 
expressed the transgene
[36]
IIGT Mice Plasmid/liposome/2–5 days 
after IIGT, the males were 
mated to females
Transmitted the foreign DNA 
to F0 offspring at frequencies 
of 4.3–92.3%; the copy number 
of the exogenous DNA was 
estimated to be less than 1 copy 
per diploid cell; no transgene 
expression in mid-gestational F0 
fetuses
[32]
Figure 2. 
There are several routes for introducing exogenous DNA into the male reproductive system. The routes for DNA 
injection are as follows: (a) STGT via rete testis; (b) EpiGT by inserting a glass pipette into the proximal region 
of caput epididymis; (c) EpiGT by inserting a glass pipette into the proximal region of cauda epididymis; and 
(d) VDGT by inserting a glass pipette into the proximal region of vas deferens.
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice Plasmid/liposome/2 days after 
IIGT, the males were mated 
to females
Transmitted the foreign DNA to 
F0 offspring at frequencies of 
50.0–84.6%; expression of lacZ 
in most (71.9%) blastocysts, but 
no expression of foreign DNA in 
the mid-gestational F0 fetuses; 
transmission of the exogenous 
DNA from F0 to F1 generation 
at frequencies from 16.1–23.1%, 
suggesting that the introduced 
DNA was chimeric in these F0 
mouse testes
[33]
IIGT Mice/rats Plasmid/liposome/3–4 days 
after IIGT, the males were 
mated to females
Transmitted the foreign DNA to 
F0 offspring at frequencies of 18% 
in rats and 20% in mice; transgene 
expression in F0 offspring; 
transmission of the exogenous 
DNA up to F4 generation
[37]
IIGT Mice/rats Plasmid/liposome/4 days after 
IIGT, the males were mated 
to females
Detection of exogenous DNA in 
the head and tail of epididymal 
sperm; also, in the ejaculated sperm 
isolated from the female uteri; 
failure to detect the exogenous 
DNA in the DNase-treated sperm, 
suggesting no integration of the 
transgene in sperm DNA
[38]
IIGT Mice Plasmid/liposome/2 days after 
IIGT, the males were mated 
to females
Although seven commercially 
available transfection reagents were 
tested for possible improvement 
of IIGT to increase copy number 
of transgenes integrated and 
transgene expression, drastic 
improvement failed; transgene 
expression indeed occurred, but the 
degree of its expression diminished 
with development; choice of 
reagents used appears not to be so 
critical for IIGT
[39]
IIGT Rats Plasmid/liposome/4 days after 
IIGT, the males were mated 
to females
Detection of foreign DNA 
(encapsulated by DMRIE-C and 
SuperFect among eight liposomes 
tested) in sperm in the cauda 
epididymis isolated 1, 4, and 
14 days after IIGT; more than 
80% of morulae expressed EGFP; 
the ratio of animals carrying 
the foreign DNA decreased as 
they developed, suggesting high 
incidence of mosaicism
[40]
IIGT Mice Plasmid (lacZ/retroviral 
integrase gene)/EP
One month after IIGT, some 
spermatocyte-like cells in 
STs expressed the lacZ gene; 
co-transfection with integrase 
gene resulted in prolonged 
expression of lacZ, suggesting 
the usefulness of integrase 
gene co-transfection for stable 
transformation of spermatogenic 
cells in vivo
[41]
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice TB or Hoechst 33342/
plasmid/EP
TB was rapidly transported to 
the epididymal portion after 
IIGT; TB reached the corpus and 
cauda epididymis within 2–4 days 
after injection; sperm isolated 
from epididymal portion had 
the exogenous DNA even after 
DNase I treatment, suggesting 
incorporation of the DNA inside 
the sperm
[42]
IIGT Mice Adenovirus Presence of the transgenes in sperm 
from 7 to 16 days after inoculation; 
transgenes are detected in the 
sperm heads in oocytes after IVF; 
the transgene product was mainly 
present in the interstitial tissue of a 
testis; it was also present in the STs 
and collected sperm; the transgene 
product was located in the head and 
the mid-piece of sperm
[43]
IIGT Fishes 
(silver sea 
bream)
Plasmid/liposome IIGT was performed 48 h before 
spawning. After mating these IIGT-
treated males to females, between 
59 and 76% of the hatched fry were 
found to be Tg; the efficiency of 
gene transfer was improved more 
than 80% by injecting multiple 
doses of the transgenes; Southern 
blot analysis showed that the 
transgene was integrated into the 
host genome
[44]
IIGT Mice Plasmid/EP To study regulatory elements 
of genes specifically active in 
spermatocytes, IIGT-EP was 
performed; in the EP-based IIGT-
treated testes, only small fraction 
of cells expressed the transgenes; 
this method can be useful for 
preliminary screening of constructs 
aimed to study in Tg mice
[45]
IIGT Mice Adenovirus/IIGT at 3 sites 
per testis
The transgene expression was 
found in Leydig cells, but no 
expression was noted in germ cells
[46]
IIGT Mice Plasmid/liposome/repeated 
injections (singly, 3 or 6 times 
3 days apart)
Repeated injections of the 
exogenous DNA led to a high rate of 
gene transfer, but failed to introduce 
high numbers of copies (more than 
1 copy per diploid cell); expression 
of transgene-derived mRNA was 
observed, although its strength 
appeared still to be very low
[47]
IIGT Mice Plasmid/liposome/3 times 
3 days apart/7–21 days after 
IIGT, the males were mated 
to females
Detection of the presence of at 
least two types of the exogenous 
DNA, intact and deleted form of 
plasmid in F0 offspring, suggesting 
degradation of the exogenous DNA 
during the process of IIGT
[48]
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice Plasmid/EP LacZ activity was detected in 
spermatogenic cells up to 4 weeks 
after IIGT
[49]
IIGT Mice Adenovirus/EP EP might be effective for 
transfecting germ cells or somatic 
cells
[50]
IIGT Mice Plasmid/PEI Transferred and expressed in 
germ cells (especially in primary 
spermatocytes); transfection into 
Sertoli cells was not observed; 
protein showed dynamic shifts in 
spermatogenic cells at different 
stages during spermatogenesis
[51]
IIGT Mice/
rabbits
Plasmid/DMSO F0 offspring (mice) expressed 
EGFP with an efficiency of 28.6%; 
also 56.3% of rabbits born were 
identified to be Tg
[29]
IIGT Shellfishes 
(Japanese 
abalone)
Naked plasmid (linearized) The gene-transfer efficiency 
of G0 in larvae (9 h after 
fertilization), juveniles (3 weeks 
after fertilization), and 1-year-old 
adults was 90%, 92.5%, and 60%, 
respectively; genomic Southern 
blot analysis showed that the 
transgene was integrated in the 
genome of the Tg abalone
[52]
IIGT Mice Linearized plasmid/liposome 
(DOTAP)/IIGT at multi-sites/
after few weeks, the males 
were mated
41% of F0 offspring exhibited 
the presence of the transgenes 
when PCR and Southern blot 
hybridization were employed; 
37% of F1 offspring obtained after 
mating of F0 offspring with wild-
type mice were Tg
[53]
IIGT Mice Linearized plasmid/EP Successful gene delivery to 
undifferentiated spermatogonia 
within the STs; about 94% of 
females after mating with the 
IIGT-treated males successfully 
sired Tg pups
[54]
IIGT Chickens Plasmid/cationic polymer The percentages of gene expression 
reached the summit and became 
stable from day 70 to 160, being 
12.7%, 12.8%, 15.9% and 19.1%, 
respectively; Southern blot showed 
that the transgene was inserted in 
their genomic DNAs
[55]
IIGT Chickens Plasmid for EGFP-lacZ dual 
reporter expression/liposome 
(Lipofectamine 2000)
Ten days post-IIGT, fluorescent 
sperms were not observed on 
semen slides; however, sperms 
positive for lacZ were detected; 
specific amplicons of EGFP and 
lacZ detectable in four of the 
six sequentially collected semen 
samples; staining with monoclonal 
antibodies demonstrated positive 
staining for subsets of testicle cells
[56]
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice Plasmid/DMSO, DMA or 
liposome (Lipofectin)/1 day 
after IIGT, each male was 
mated
The presence of transgene in the 
progeny (80% for PCR positive 
when repeated injection was done; 
50% for RT-PCR positive) in the 
case of liposome was used; 55.5% 
for PCR positive, but 22.3% for 
RT-PCR positive in the case of 
DMSO was used; RT-PCR analysis 
of PCR positive animals showed 
EGFP expression in blood cells; 
repeated (4 times) injections 
of DNA complexes can affect 
spermatogenesis
[57]
IIGT Mice Plasmid/liposome 
(Lipofectamine 
2000)/6 weeks after IIGT, 
each male was mated
38.46% of F0 positive for 
transgenes in the case of PCR; 
30.77% by Southern blotting; 
36.36% of F1 were positive for the 
transgene; expression of EGFP is 
recognized
[58]
IIGT Mice Plasmid/liposome 
(ExGen500)/at different 
angles into the testes of 7-day-
old males
Transgene efficiencies were 
11.76% (2/17), 14.29% (3/21), 
and 11.11% (2/18), respectively; 
semi-quantitative RT-PCR analysis 
further showed that the introduced 
GFP gene was expressed in 3/9 
integration mice; GFP expression 
was observed in sperm from the F0 
fetuses and F1 pups
[59]
IIGT Mice Linearized plasmid/EP Electroporated testis expressed 
EGFP even 80 days after IIGT; 
EGFP expressing germ cells were 
discernible in the STs; after mating 
with the EP-based IIGT-treated 
males with normal females, the 
resultant Tg pups showed tissue-
specific expression of transgene
[60]
IIGT Mice Plasmid/liposome (PEI) Twenty days after IIGT, the 
transgene-derived fluorescence was 
detected in the testis and sperm; 
foreign DNA was successfully 
expressed in the treated mice: 4.0% 
for G0 and 30.23% for F1
[61]
IIGT Mice Plasmid/liposome (DOTAP) The Tg positive rate in mouse 
F1 offspring was 39.69%; gene 
transmission beyond F2 generation; 
the transgene was expressed in the 
ovaries
[62]
IIGT (in 
vitro)
goats Plasmid/EP Cultivation (organ culture) of STs 
isolated from the IIGT-EP-treated 
testis led to expression of GFP 
24 h after EP; green fluorescence 
was observed at best 23 days after 
EP-based IIGT
[63]
IIGT Rats GFP-expressing plasmid/EP Possible integration of transgene 
into the genome of the 
spermatogonial cells; a transgenic 
disease model displaying alpha 
thalassemia was successfully 
generated with EP-based IIGT
[64]
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Method Species DNA/transfection method Outcome (note) References
IIGT Mice Linearized Plasmid/hypotonic 
Tris-HCl solution
Successful internalization of the 
transgene in spermatogonia within 
STs; such IIGT-treated males 
generated Tg progeny by natural 
mating
[65]
IIGT Mice Plasmid/BMPs-PEI DNA complexed with BMPs-PEI 
successfully reached the cytoplasm 
and the nucleus of spermatogenesis 
cell; the transgene was expressed in 
the testes of Tg F0 mice; the ratio of 
Tg F0 offspring was 88%
[66]
IIGT Goats Plasmid/EP Successful transfer of the transgene 
into STs and testicular cells; 
chromosomal integration of the 
transgene and its expression in sperm; 
natural mating of a pre-founder buck 
produced a Tg baby goat
[67]
STGT Mice/pigs Plasmid/liposome (obtained 
from Gibco)
In mice, 8.0–14.8% of STs expressed 
the introduced LacZ gene, and 
7–13% of epididymal sperm had the 
foreign DNA; in pigs, foreign DNA 
was also incorporated into male 
germ cells, and 15.3–25.1% of the 
STs containing germ cells expressed 
the LacZ gene
[68]
STGT Rats Adenovirus Expression of the transgene in Sertoli 
cells and persisted for at least 10 days
[35]
STGT Mice Plasmid/EP Specific lacZ expression only 
in haploid spermatid cells; 
spermatogenic differentiating 
cells maintained the transfected 
lacZ expression after more than 2 
months of transfection, suggesting 
that spermatogenic stem cells 
and/or spermatogonia could also 
incorporate foreign DNA
[69]
STGT Mice Plasmid/EP Transient expression of GFP 
in the innermost region of the 
testis uniformly, but confined to 
spermatogenic cells and Sertoli 
cells within the STs; GFP was 
detected in the spermatogenic 
cells even 2 months after EP; no Tg 
offspring were obtained
[70]
STGT Mice Plasmid/EP After EP-based STGT, fluorescent 
sperm were collected from the 
STGT-treated STs; these fluorescent 
sperm were found to have the 
ability to produce Tg offspring, 
when ICSI was performed
[71]
STGT Mice adeno-, adeno-associated-, 
retro-, and lentiviral vectors
Transduction with either adeno- or 
lentiviral vectors led to reporter gene 
expression for more than 2 months 
after STGT; lentiviral vectors 
used to express the c-kit ligand 
in Sl/Sl(d) Sertoli cells restored 
spermatogenesis; lentiviral vectors 
failed to infect spermatogenic cells
[72]
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Method Species DNA/transfection method Outcome (note) References
STGT Mice Plasmid/EP By electrotransformation of a 
complete cDNA in Sertoli cells, 
defective spermatogenesis was 
rescued in infertile Sl(17H)/Sl(17H) 
mutant mice
[73]
STGT Mice Plasmid/liposome 
(noncommercial cationic 
lipids)
As early as 48–96 h post-injection, 
lacZ expression was observed within 
both immature and differentiated 
germ cells; by 40 days post-injection, 
it was restricted to the most 
immature germ cells; after mating 
with females, the transgene was 
transmitted to the offspring, but 
remained episomal
[74]
STGT Mice Adenovirus Strong expression in Sertoli cells 
after STGT, but no expression in 
germ cells
[46]
STGT Mice Retrovirus Transduction of spermatogonial 
stem cells with an average 
efficiency of 2.8%; the transgene 
was transmitted stably and 
expressed in the next generation
[75]
STGT Mice Plasmid/EP STGT was performed to examine 
testis-specific gene promoter 
activity; successful in vivo transient 
transfection to living mouse testis 
was achieved
[76]
STGT Mice Plasmid/EP LacZ activity was detected in 
spermatogenic cells up to 8 weeks 
after EP-based SMGT
[49]
STGT Hamsters Plasmid/EP Sixty days following gene transfer, 
expression of the transgene can be 
detected in epididymal sperm
[77]
STGT Mice Plasmid/EP The transgene products were found 
on the head and mid-piece regions 
of mature epididymal sperm
[78]
STGT Mice Plasmid/EP A fluorescent reporter protein 
expressed in male germ cells
[79]
STGT Mice Plasmid RNAi targeting 
EGFP/EP
Sertoli cells were the main 
transfected cells
[80]
STGT Mice Plasmid/EP STGT is useful for testing the 
tissue-specific promoter activity 
included in the construct in vivo
[81]
STGT Mice Adenovirus Sertoli cell-specific expression of GFP [82]
STGT Mice Lentivirus All male pre-founder mice 
produced Tg pups with an overall 
success rate of over 60%
[83]
STGT Mice Lentivirus 14.3% of the lentivirus-injected 
mice successfully produced Tg 
pups; eight Tg founders were 
obtained from the total 336 pups; 
the Tg efficiency was around 2.4%
[84]
EpiGT Rats Plasmid/EP After 72 h, the initial segments 
had intense fluorescence in the 
cytoplasm of the epithelial cells
[85]
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In the following sections, the TMGT-related experiments will be mentioned in 
more detail.
2. Historical background of TMGT-related experiments
2.1 IIGT-related experiments
Between 1994 and 2006, over 20 reports on IIGT-related experiments were 
reported using various animal models such as mice, rats, hamsters, rabbits, boar, 
goats, chicks, fishes, and shellfishes [29, 31–41, 43–53, 68]. The DNA used were 
mainly plasmid DNA that had been mixed with calcium phosphate, liposomes/
lipids, polyethylenimine (PEI), or DMSO, all of which were intended to facilitate 
uptake of DNA by sperm or spermatogenic cells [29, 31–34, 37–40, 44, 47, 48, 51, 
68]. The method to use in vivo EP towards the entire testis after IITG with naked 
plasmid DNA was also employed [36, 41, 45, 49]. Furthermore, adenoviral vectors 
were introduced by IIGT [35, 43, 46, 50].
Through these works, the following information became available:
Method Species DNA/transfection method Outcome (note) References
EpiGT Mice Plasmid/lipid (FuGENE 6) Transfection was observed in 
39.70% of epithelial cells after 
2 days and in 31.77% after 7 days; 
the presence of the transgene in 
the DNA isolated from the treated 
epididymides (by PCR); GFP gene 
expression appeared in large areas 
of the cauda epididymis even after 
2 weeks post-EpiGT
[86]
VDGT Mice/rats Plasmid Uptake of exogenous DNA 
occurred in 60–70% of the 
spermatozoa after in vitro or in 
vivo treatments; positive signal 
was detected in the sperm nucleus 
and was not affected by DNase 
treatment
[87]
VDGT Mice Mixture of linearized and 
circular plasmids
From 53 newborns, four were 
found positive by PCR for the 
GFP gene; some tissues showed 
expression for GFP
[88]
VDGT Mice Plasmid/liposome 
(Lipofectamine)
Maximum of 6.8% in the epithelial 
cells of the vas (for lacZ staining); 
13.3% after employing the GFP 
gene construction; expression of 
the GFP gene appeared from 1 week 
up to 3 months following injection
[89]
1TMGT can be defined as a method for in vivo gene delivery towards male reproductive systems (testis, epididymis, 
and vas deferens) and includes intratesticular injection-based gene transfer (IIGT), seminiferous tubule-mediated 
gene transfer (STGT), epididymis-mediated gene transfer (EpiGT), and vas deferens-mediated gene transfer 
(VDGT).
Abbreviations: BMPs, bacterial magnetic particles; DMSO, dimethyl sulfoxide; DOTAP, N-[1-(2,3-Dioleoyloxy)
propyl]-N,N,N-trimethylammonium methyl sulfate; DMA, N,N-dimethylacetamide; EP, electroporation; GFP, green 
fluorescent protein; IVF, in vitro fertilization; PEI, polyethylenimine; STs, seminiferous tubules; Tg, transgenic; TB, 
trypan blue.
Table 1. 
Summary of testis-mediated gene transfer (TMGT)1-related studies.
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i. Transgene expression in a testis after IIGT: IIGT using an adenoviral vector 
resulted in preferential transgene expression in Leydig cells [46]. Mogas 
et al. [43] reported that transgene-derived protein is mainly present in the 
interstitial tissue of a testis, and in STs 7–16 days after inoculation. Li et al. [51] 
demonstrated that plasmid DNA mixed with PEI can be transferred within STs 
after IIGT and expressed in primary spermatocytes, but not Sertoli cells.
ii. Detection of transgenes and expressed products on the epididymal or  
ejaculated sperm: According to Yonezawa et al. [40], foreign DNA encapsulated 
by DMRIE-C and SuperFect can be detected by PCR in the cauda epididymis-
derived sperm isolated 1, 4, and 14 days after IIGT. The exogenous DNA was also 
detectable in the ejaculated sperm collected from the uterine horn of the females 
in the morning after mating with the IIGT-treated males [31, 38].
iii. Transgene expression in the F0 offspring obtained after mating with the 
IIGT-treated males: PCR analysis revealed that detection of the transgenes in 
the mid-gestational fetuses was found at frequencies ranging about 50–85% [39]. 
However, the copy number of the transgenes in those fetal DNA are estimated 
to be <1 copy per diploid cell [32]. PCR/slot blot analyses revealed that 41% of 
F0 offspring had the transgenes [53]. Ogawa et al. [34] reported that 80% of 
blastocysts exhibited the transgene-derived lacZ gene coding for β-galactosidase, 
one of the key enzymes consisting of lactose operon. Sato et al. [39] reported that 
lacZ expression was evident in most (72%) of the blastocysts, but neither expres-
sion of the LacZ gene nor its mRNA was found in the mid-gestational fetuses. 
More than 80% of morulae expressed EGFP, but the ratio of animals carrying the 
foreign DNA decreased as they developed, and only some of the progeny were 
foreign DNA-positive with high incidence of mosaicism [40].
iv. Transgene transmission to the next generation: Gene transmission to F1 
offspring was at frequencies ranging about 16–23%, but when F2 offspring 
was obtained from mating normal female with F1 male offspring, about 94% 
of F2 offspring had the transgenes, suggesting that the introduced DNA 
was chimeric in these F0 mouse testes [38]. On the contrary, He et al. [53] 
demonstrated that the transgene transmission rate from F0 to F1 generation 
was 37%, suggesting that the transgene transmission rate was similar to the 
Mendelian law of inheritance.
In 2007 and onward, attempts to improve IIGT systems were made by several 
laboratories to enhance the gene delivery efficiency [54–67]. In the following 
sections, we will describe several examples [(v) to (x)] about the improvement 
of IIGT, in vitro assessment for gene expression after IIGT or possible mechanism 
underlying IIGT.
v. IIGT at a young stage: In mammalian testis, spermatogenesis occurs in the 
STs of a testis (Figure 3d). In the ST, there are spermatogenic cells called 
spermatogonia (spermatogonial cells) that can be further matured into 
spermatocytes and spermatids. Spermatogonia are largely divided into two 
types, type A and type B cells. The former undergoes active mitosis and divide 
to produce type B cells. The type B cells divide to give rise to spermatocytes 
and spermatids, which move towards the lumen of the ST as they mature. 
According to Hui-ming et al. [59], type A spermatogonia first appear between 
3 and 7 days postnatally in mice and are the only immortalized diploid cells. 
They considered that if these type A spermatogonia are stably transfected with 
the exogenous DNA, the transfected cells would be able to produce mature Tg 
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sperm leading to production of Tg mice through natural fertilization. Based 
on this hypothesis, they performed IIGT using GFP-expressing plasmid DNA 
encapsulated by the ExGen500 transfection reagent on 7-day old male ICR 
mice. When these treated mice reached different stages of sexual maturity (6, 
12, and 24 weeks of age), they were mated with normal females. The resulting 
pups were identified as Tg, with efficiencies of 11–14%. They observed GFP 
expression in sperm cells isolated from F0 and F1 pups. They referred to this 
technology as “type A spermatogonia-mediated gene transfer” (TASMGT).
vi. EP-based IIGT: Majumdar’s group developed a method for generating Tg 
mice by directly injecting the desired gene into the testis followed by in vivo 
EP [54]. In this method, one of the testis was surgically exposed for DNA 
injection (Figure 1a) and the other contra-lateral testis was removed. An 
improved version of this EP-based IIGT was provided by Usmani et al. [60], 
who introduced the transgenes to both testes of mice directly from the outside 
(Figure 3a), prior to in vivo EP. They employed a two-step EP in which four 
60 V electric pulses (50 ms each with an inter-pulse interval of 1 s) in one 
direction (forward direction) (Figure 3b) and four more pulses after chang-
ing the sides of the electrodes (reverse direction) (Figure 3c). The EP-based 
IIGT-treated testis expressed EGFP from the introduced transgenes even at 
80 days of age. Furthermore, fluorescent germ cells were discernible in the STs 
of those mice (Figure 3d). F1 offspring that were generated after mating the 
IIGT-EP-treated males with normal females showed tissue-specific expression 
of transgenes. This improved procedure is based on non-surgical gene delivery 
using a two-step EP, which appears to be a user-friendly technique for a person 
who is less experienced in performing surgery.
vii. In vitro EP-based IIGT: It is difficult to apply IIGT in the testis of larger 
animals such as goats, because the size of the testis is much bigger than that of 
smaller animals such as mice and rats. Raina et al. [63] hypothesized that IIGT 
may be possible when in vitro gene delivery is performed towards the testis 
dissected from goats. They slowly injected GFP-expressing plasmid DNA into 
the interstitial space at eight different sites of the isolated testis using a 1-mL 
syringe (Figure 4a). Then, the testis was subjected to in vitro EP using a pair of 
tweezer-type electrodes (Figure 4b). After that, ST was partially dissociated 
and placed under in vitro cultivation for checking GFP expression at regular 
intervals (Figure 4c, d). A strong green fluorescence signal was observed 24 h 
after EP and its expression was continuously observed for as long as 23 days 
post-EP. The authors mention that the results of this study cannot be applied 
straightforwardly for in vivo studies, but the in vitro transfection of ST using 
EP will provide valuable baseline information, prior to IIGT in vivo.
viii. IIGT using a simple hypotonic solution: Majumdar’s group have developed a 
method to generate Tg mice by directly injecting the desired gene in the testis 
followed by in vivo EP, as mentioned above [54, 60]. This technique is less com-
plicated for small animal like mice but appears to not be feasible for transgenesis 
in large animals, because these animals have larger testes and greater scrotal 
thickness, to which it is difficult to standardize voltage parameters. To overcome 
this difficulty, they developed an alternative technique for making Tg mice by 
hypotonic shocking male germ cells for gene delivery. According to Usmani et al. 
[65], treatment with hypotonic Tris-HCl solution reduced osmolarity and led to 
hypotonic-swelling of germ cells. The hypotonic-swelling eventually killed the 
cells with increased hypotonicity, but led to the uptake of surrounding molecules 
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such as nucleosides inside the cell. The authors hypothesized that a hypotonic Tris-
HCl solution at a certain hypotonic concentration might allow the germ cells to 
internalize the surrounding solutes like DNA in vivo without being killed and the 
sperm produced from transfected germ cells may carry a desired DNA fragment 
(transgene) to generate Tg animals. Usmani et al. [65] suspended the linearized 
plasmid DNA (transgenes) in hypotonic Tris-HCl solution (pH 7.0) and simply 
performed IIGT to internalize the injected transgenes in the genome of sper-
matogonia residing at basal compartment of tubules. As a result, such males 
successfully generated Tg progeny by natural mating. This technique is easy and 
simple and does not require expensive apparatuses like electroporators. Usmani 
et al. [65] proposed that such a procedure enables researchers to generate their 
Figure 3. 
EP-based IIGT in mice. a-c. Schematic illustration for EP-based IIGT. After IIGT towards both testes (a), they 
are held by a pair of tweezer-type electrodes and then subjected to the first in vivo EP (b). The second EP was 
next performed by changing the direction of electric pulse (c). (d) Structure of a ST. The colored spermatogenic 
cells and Sertoli cells indicate cells successfully transfected by the exogenous DNA that have been instilled within 
a lumen of ST.
Figure 4. 
In vitro EP-based IIGT in goats. The isolated goat testis is subjected to IIGT with a total of eight repeated 
injections from different directions (a). Then, the entire testis is hold by a pair of electrodes prior to EP (b). 
After that, the EP-treated STs are partially dissected and subjected to in vitro cultivation (c). By this, the 
transgene expression on the spermatogenic cells of STs can be monitored continuously (d).
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own Tg animals, instead of outsourcing, and would drastically minimize the 
time required for studies on functional genomics.
ix. IIGT using nanoparticles: It has previously been reported that nanoparticles 
such as magnetic nanoparticles, mesoporous silica nanoparticles, and hal-
loysite clay nanoparticle can be used as a vehicle for delivering exogenous 
DNA to sperm of various animals, such as boar and bovine [30, 94–96]. 
However, these early reports are confined to in vitro events. Wang et al. [97] 
applied this technology to IIGT using bacterial magnetic particles (BMPs)/
PEI complex-conjugated foreign DNAs (BMP-PEI-DNA complex). According 
to Wang et al. [97], BMPs help to reduce the toxicity of the PEI, an efficient 
gene transfer agent, and assist gene delivery in vivo. After performing IIGT in 
mice, the testis was returned to the original position, and a neodymium-iron-
boron magnet with an intensity of 600 milliteslas (mT) was placed onto the 
surface of the abdomen to facilitate gene delivery towards the spermatogenic 
cells. The authors report that this procedure is not harmful to the function-
ing of the testis. They reported that the clusters of BMP-PEI-DNA complex 
successfully reached the cytoplasm and the nucleus of spermatogenic cell and 
expressed in the testes of F0 mice. The resulting F0 mice could transmit the 
introduced transgene to the offspring with efficiencies of 88%.
x. Possible mechanism for IIGT-mediated gene delivery to sperm: When 
intratesticular injection of a DNA-containing solution into the interstitial 
space of a testis is performed, the fate of the injected solution is largely 
divided into two routes. This was first assessed by Sato et al. [42] who 
employed trypan blue (TB) as dye to visualize the transferring solution. One 
route is when a solution is transferred to the epididymal ducts, and the other 
route is when a solution is transferred to the lumen of the STs (Figure 5). 
After the intratesticular injection of 30 μL TB, the dye was rapidly trans-
ferred via rete testis to the proximal segment of caput epididymis [42]. One 
day after the injection, the dye was observed in the middle segment of caput 
epididymis. This was also confirmed by a previous observation using PCR 
analysis, which revealed the presence of the exogenous DNA in the sperma-
tozoa isolated from caput epididymis [31]. Furthermore, the exogenous DNA 
can be detected in the ejaculated sperm collected from the uterine horn 1 
day after mating with females [31]. Thus, it is reasonable to consider that the 
exogenous DNA injected into the interstitial space of a testis is rapidly trans-
ferred to the epididymal ducts and taken up by epididymal sperm in situ.
Only a minor portion of the solution injected into the interstitial space of a testis 
is transferred inside the STs. This may be elicited by mechanical shearing of STs 
upon insertion of a needle or glass capillary. To increase the transfection efficiency 
in the spermatogenic cells existing within STs, repeated needle insertions (over at 
least three times from different sites) have been employed by some research groups 
[34, 46, 53, 59, 63]. At present, it remains unknown how many STs are indeed 
transfected by this treatment. Usmani et al. [65] reported that spermatogenic cells, 
including spermatogonia present within STs, are transfected after IIGT and subse-
quent in vivo EP using fluorescent marker genes.
2.2 STGT-related experiments
ST is a tubular structure packed in a testis, which contains spermatogenic cells, 
such as spermatogonia, a precursor for mature sperm, and maturing sperm cells 
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(spermatocytes and spermatids), and Sertoli cells, which support the prolifera-
tion and differentiation of spermatogonia (Figure 3d). If the exogenous DNA is 
introduced within a lumen of the ST, it is possible to transfect those spermato-
genic cells, from which transfected spermatozoa are transported via epididymal 
ducts and finally ejaculated upon mating with estrous females. As a result, the 
introduced exogenous DNA will be transmitted to oocytes via fertilization with 
the transfected sperm.
To our knowledge, STGT was first performed in 1997 by two groups: Blanchard and 
Boekelheide [35], with rats using adenoviral vector, and Kim et al. [68], with mouse 
and pigs using liposomally encapsulated plasmid DNA. The aim of the former group 
was to study transgene expression in the adult rat testis in vivo. They demonstrated that 
there was transgene expression in Sertoli cells and principal cells of the epididymis, and 
expression persisted for at least 10 days. The latter group demonstrated that in mice, 
8.0–14.8% of STs expressed the introduced transgene, as evaluated by histochemical 
staining for the lacZ gene, and 7–13% of epididymal sperm had the exogenous DNA, as 
evaluated by PCR analysis. In pigs, 15–25% of the STs contained lacZ-positive germ cells. 
They suggested that STGT can be used as a powerful tool for producing Tg livestock.
In 1998, Yamazaki et al. [69] employed STGT for examining transcriptional 
regulatory elements of spermatogenic specific genes. After injecting DNA into 
STs, subsequent in vivo EP was used to enhance DNA uptake by spermatogenic 
cells. Based on these experiments, they suggested that spermatogenic stem cells 
and/or spermatogonia can incorporate foreign DNA, and that the transgene could 
be transmitted to the progenitor cells derived from a transfected proliferating 
germ cell. Later, the same group [70] examined the possibility to create Tg off-
spring using STGT coupled with in vivo EP (EP-based STGT). Although long-
lasting transgene expression could be detected in the spermatogenic cells even 2 
months after EP, no Tg offspring were obtained after natural mating with normal 
adult females.
Huang et al. [71] used the EP-based STGT towards an entire mouse testis after 
intratubular injection of plasmid DNA that coded for fluorescent genes. To trace the 
fate of transfected spermatogenic cells, they obtained fluorescent sperm by fluores-
cence activated cell sorting (FACS), and performed ICSI to obtain their offspring. 
Almost all the individuals produced from fluorescent sperm were Tg. The authors 
Figure 5. 
Possible mechanism of how the exogenous DNA introduced into the interstitial space of a testis is transmitted to 
epididymal sperm or to spermatogenic cells within a ST.
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claim that this is the first report of gene transfer into germ cells and subsequent 
production of Tg offspring.
STGT appears to be the direct approach to transfect spermatogenic cells in 
situ, but most experiments [46, 49, 51, 72–84] have been confined to successful 
transfection of spermatogenic cells and Sertoli cells for rescuing damaged/inactive 
Sertoli cells, in vivo testing of efficiency of RNA interference (RNAi), or estab-
lishment of an in vivo assay system to evaluate the promoter activity of the gene 
of interest. There have been no trials to create Tg offspring through STGT. Only 
some groups have tried to test the possibility of creating Tg animals by STGT. For 
example, Celebi et al. [74] performed STGT using circular plasmid carrying the 
lacZ reporter gene mixed with noncommercial cationic lipids. These injected males 
were mated with wild-type females and the progeny were analyzed by PCR and 
Southern blot assay. They demonstrated that the transgenes were transmitted to 
the offspring, but remained episomal, since it was found in the tail of the young 
animals and was lost at adulthood. Therefore, the plasmid seemed to be lost during 
the numerous germ cell divisions. This plasmid stayed in some tissues, such as 
in the skeletal and cardiac muscles. No integrative forms have yet been found with 
the use of circular DNA. Kanatsu-Shinohara et al. [75] described a novel approach 
for producing Tg animals by transducing spermatogonial stem cells in vivo using a 
retroviral vector by STGT. When these injected males were mated with wild-type 
females, Tg offspring were obtained with an efficiency of 2.8%. The transgene 
was transmitted stably and expressed in the next generation. The authors, thus, 
concluded that this technique will be useful as an alternative to the pre-exiting 
microinjection-based transgenesis, as well as provide a means for analyzing the 
self-renewal and differentiation processes of spermatogonial stem cells in vivo. 
Sehgal et al. [83] described a technique for the generation of Tg mice by infection 
of spermatogonial stem cells with recombinant lentiviruses expressing EGFP with 
a high rate of success. When the infected males were mated to normal females, over 
60% of the delivered pups were found to be Tg. Li et al. [84] employed methods 
similar to those of Kanatsu-Shinohara et al. [75] and Sehgal et al. [83] and reported 
that the Tg efficiency is around 2.4%, which is similar to the previous report of 
Kanatsu-Shinohara et al. [75].
2.3 EpiGT-related experiments
Epididymal sperm present on the ducts of caput and cauda epididymides 
and epididymal epithelial cells can be targeted for transfection by the exogenous 
DNA. Kirby et al. [85] performed intraluminal injections (2–5 μL) of plasmid DNA 
into the lumen of an initial segment tubule of caput epididymis (Figure 2b), and 
subsequent in vivo EP towards the injected portion to examine the function of 
epididymal epithelial cells, which are thought to play critical role in sperm matura-
tion during transport through epididymides. They concluded that this procedure 
is useful for elucidating the activity of promoter elements included in the injected 
plasmid that may not be identified when traditional in vitro methods are used. 
Esponda and Carballada [86] injected plasmid DNA mixed with the lipid FuGENE6 
into the lumen of mouse cauda epididymis (Figure 2c). Successful transfection was 
observed in about 40% of cells after 2 days and in about 32% after 7 days, and then 
diminished progressively over time. Gene expression continued up to 15 days after 
gene injection and occupied about 22% of the area of the tubules. They concluded 
that intraluminal injections of exogenous DNA are effective for the study of 
epididymal physiology or to change the fertilizing ability of sperm. These studies 
are not aimed to create Tg animals, but they hold a potential to transfect epididymal 
sperm as a useful Tg tool.
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2.4 VDGT-related experiments
In 1998, the Esponda’s group [87] first attempted to examine whether exog-
enous plasmid DNA introduced into the lumen of the proximal region of the vas 
deferens could be taken up by mouse and rat sperm (Figure 2d). They demon-
strated that 60–70% of sperm recovered 6 h after DNA injection had positive 
signal for successful transfection in their sperm nucleus, which was not affected 
by DNase treatment. This was also confirmed by PCR and slot blot analyses. 
They concluded that sperm within the vas deferens had the ability to incorporate 
exogenous DNA, which can be transferred to their nuclei, and vas deferens secre-
tions do not block these capacities. In 2000, the same group [88] showed that this 
VDGT is useful for production of Tg mice. They injected plasmid DNA encoding 
GFP into the lumen of mouse vas deferens. The night after injections, males were 
mated with normal estrous females, and the offspring were analyzed. About 8% 
(4/53) of the newborns delivered expressed the GFP gene. They concluded that 
VDGT is a simple alternative to the pre-existing microinjection-based production 
of Tg animals and can be used for species in which the microinjection procedure 
is not feasible. This technology was later found to also be useful for transfection 
of epithelial cells of the vas deferens using a direct injection of DNA-liposome 
complexes, which could modify vas fluid contents [89].
3. Historical background of SMGT-based AI
As mentioned previously, AI of transfected sperm with exogenous DNA through 
SMGT is a highly convenient route for producing Tg animals. To our knowledge, 
Sperandio et al. [98] was the first to demonstrate its usefulness in domestic animals, 
such as bovine and swine. They performed AI towards ten sows with boar sperm 
cells that had been preincubated with plasmid DNA and obtained 82 offspring. 
Southern blot analysis of the DNA extracted from the animal tails showed that five 
animals were Tg and contained sequences complementary to the exogenous plasmid 
DNA that appeared to be rearranged compared to the original plasmid. From this 
study, it was suggested that SMGT-AI can be successfully adapted for the genera-
tion of Tg livestock. Yonezawa et al. [99] tested whether liposome-peptide (derived 
from human protamine)-DNA complex (LPD), a new reagent known to stabilize 
transfection in cultured cells, was useful to increase the efficiency of SMGT. They 
performed AI using rat epididymal sperm that had been incubated in a solution 
containing GFP expressing plasmid DNA and LPD complex. Expression of GFP 
was detectable in the morulae isolated from the treated animals. Furthermore, the 
AI-treated animals produced pups carrying foreign DNA.
This SMGT-AI is applicable to avian species. Yang et al. [100] performed AI 
using freshly-ejaculated chicken sperm that had been incubated in the presence of 
plasmid DNA and liposome, and found that about 4% (2/53) newly hatched chicks 
was identified as Tg. Harel-Markowits et al. [101] employed restriction enzyme-
mediated insertion (REMI) to increase the efficacy of the transfection towards the 
isolated chicken sperm. REMI was used to insert exogenous DNA linearized with 
a restriction enzyme that cuts the genomic DNA at sites that enable the exogenous 
DNA to integrate via its matching cohesive ends [102, 103]. Following insemination 
with sperm transfected with linearized DNA, restriction enzyme, and liposome, 
they obtained Tg offspring. Furthermore, when chicken sperm are incubated in a 
solution containing plasmid DNA and DMSO or N,N-dimethylacetamide (DMAc) 
and subsequently subjected to AI, the resultant newborn chicks have the trans-
gene, with efficiencies of 38% (for the DMSO-treated group) and 19% (for the 
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DMAc-treated group) [104]. However, Chaparian et al. [105] recently reported that 
they were unable to create Tg chicks by SMGT-AI.
4. Exosomes as a possible carrier to deliver genetic materials to sperm
Exosomes, membrane-enclosed sub-cellular microvesicles shed from most cell 
types, are present in a wide variety of body fluids [106]. Recently, it was found that 
they can mediate various effects on the behavior of recipient cells, since they contain 
cytokines, growth factors, and membrane proteins [107]. Furthermore, they contain 
a substantial amount of small and functional RNA molecules, called microRNAs 
(<100 nucleotides in length) [108], which could potentially control gene expression 
of various endogenous genes. It has recently been shown that these exosomes are (1) 
found in human semen [109], (2) involved in sperm maturation process during the 
transit along the male epididymal tracts [110], (3) accumulated in mature spermato-
zoa nuclei [111], and (4) delivered to oocytes through fertilization [112].
Notably, there are some reports describing non-Mendelian germline-inde-
pendent inheritance of phenotypes in the absence of any classically identifiable 
mutation or predisposing genetic lesion in the genome of individuals who develop 
the disease [113–115]. For example, Cossetti et al. [116] performed subcutaneous 
inoculation of EGFP-expressing human melanoma cells into an immunocompro-
mised mouse, from which EGFP RNA was released from the grafted melanoma 
cells, delivered to the bloodstream, and finally brought to sperm. When epididymal 
sperm isolated from these tumor-bearing males were examined carefully, the EGFP 
RNA was found to be tightly associated with the extracellular fraction of these 
mature sperm. They termed this phenomenon “soma-to-germ line transmission of 
information,” and thought that exosomes may be involved in this phenomenon as 
the carrier to deliver EGFP RNA. The findings of Cossetti et al. [116] appear to be 
well correlated with those obtained from the TMGT-related experiments done at 
earlier stages of IIGT development, which include (1) non-Mendelian transmission 
of the exogenous DNA in the offspring obtained [33], (2) extreme low copy number 
of the exogenous DNA (<1 copy per diploid cell) transmitted to these offspring 
[32], (3) mosaic expression of the exogenous DNA in the offspring (blastocysts) 
obtained [33, 40], and (4) reduction in the number of offspring carrying the 
exogenous DNA during development [40]. As mentioned in Section 2.1 (x), parts of 
a solution introduced into the interstitial space of a testis is transferred to the excur-
rent ducts of epididymides, and the exogenous DNA may be taken up by the extra-
cellular fraction of epididymal sperm, possibly through exosomes. We detected the 
presence of exogenous DNA in the DNase I-treated epididymal sperm, which have 
been isolated from the IIGT-treated males [42]. This may be due to the fact that 
exosomes can protect its exogenous DNA against DNase I-mediated digestion.
Notably, in their review article, Jiang and Gao [117] demonstrated that exo-
somes can be used as naturally occurring cell-to-cell transporters or as novel bio-
carriers for gene and drug delivery. These exosomes are naturally secreted by the 
cells and pass through additional biological barriers. They are more biocompatible 
and biodegradable and can avoid immune response which is most likely due to 
the surface expression of the complement regulatory proteins, such as CD55 and 
CD59. For these natural characteristics, exosomes are being extensively explored 
as gene delivery vehicles. For example, in 2011, Alvarez-Erviti et al. [118] first 
demonstrated that exosomes are useful for delivering short interfering (si)RNA to 
the mouse brain. They engineered dendritic cells to express lysosome-associated 
membrane protein 2 (Lamp2) isoform (Lamp2b), an exosomal membrane protein 
fused to a neuron-specific peptide. Following that, exosomes were isolated from 
Gene Editing - Technologies and Applications
20
the gene-engineered dendritic cells and loaded with siRNA using electropora-
tion and were administered intravenously to mice. As a result, the targeting 
peptide was shown to be successfully delivered to the brain. The concomitantly 
delivered siRNA caused reduced expression of a target protein associated with the 
pathogenesis of Alzheimer’s disease. Furthermore, Lin et al. [119] proposed that 
exosomes can be a good carrier to introduce various cargoes, including plasmid 
DNA, into a cell. They prepared a mixture composed of purified exosomes 
isolated from HEK293FT cell line, pEGFP-C1 plasmid DNA, and Lipofectamine 
2000 liposomes in vitro. During the incubation at 37°C for 12 h, exomes and 
liposomes are fused together and the exogenous plasmid DNA becomes incorpo-
rated into exosome-liposome hybrid nanoparticles. Transfecting mesenchymal 
stem cells (MSCs), which cannot be transfected by the liposome alone, with this 
complex resulted in successful generation of fluorescent cells when evaluated by 
FACS. Now, an exosome-based transfection kit, possibly based on this principle, is 
commercially available: Exo-Fect Exosome Transfection Kit (System Biosciences). 
We confirmed the usefulness of this kit by in vivo transfecting oviductal epithelial 
cells through intraoviductal instillation of a solution prepared using this kit. 
Some oviductal epithelial cells were found to be fluorescent after transfection 
with a plasmid expressing GFP (unpublished results). Thus, it may be possible 
to transfect isolated sperm by incubating plasmid DNA and exosome/liposome 
hybrid vesicles provided from the Exo-Fect Exosome Transfection Kit, prior to AI 
as mentioned below.
5. Genome-editing sperm
Gene modification based on recently developed techniques such as zinc-finger 
nucleases (ZFNs), TAL effector nucleases (TALENs), and clustered regularly 
interspersed short palindromic repeats/CRISPR-associated protein 9 (CRISPR/
Cas9) are now recognized as a revolutionary genetic engineering tool in vitro and 
in vivo [120–124]. Three types of endonucleases from ZFNs, TALENs, and CRISPR/
Cas9 have been developed to promote precise genome editing at a target gene. All 
these enzymes have a DNA-binding ability and an ability to elicit double-strand 
DNA break (DSB) at a target genomic locus. Subsequently, in the absence of a 
homologous template to repair, nonhomologous end joining (NHEJ) occurs and 
causes small insertions or deletions (termed “indels”). In the presence of a tem-
plate donor DNA, site-specific recombination through homology-directed repair 
(HDR) occurs. Generally, the frequency of NHEJ is thought to be higher than that 
of HDR in most of the cell types [125]. Table 2 shows comparison among these 
three technologies.
ZFNs are the first engineered endonucleases [127] that combine the DNA 
recognition ability of zinc-finger protein (called zinc-finger motifs) and 
restriction enzyme Fok I to introduce DSB [120–124]. In 2005, Urnov et al. 
[128] first demonstrated that ZFNs are effective as a genome editing system in 
the human cells.
TALENs are similar to ZFNs and require a string of TALEN motif (consisting of 
a series of 33–35 amino acid repeats) to bind to the specific sequence of a target gene 
and Fok I enzyme to introduce DSB [120–124]. TALENs provide more flexibility 
to the target sequences since ZFNs are known to be more active towards GC-rich 
region, whereas TALENs can be assembled to the target AT-rich regions [120–124].
Since both ZFNs and TALENs require assembling of an array to build each set, 
which is a complex and time-consuming process [124], CRISPR/Cas9 has become the 
favorite because of its easy application. CRISPR/Cas9 requires only two components, 
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the Cas9 nuclease and a single-guide RNA (sgRNA), which is a short sequence to 
guide the Cas9 protein to a target site. More importantly, these events are performed 
by transient interaction of Cas9 and sgRNA, whereby chromosomal integration of the 
CRISPR components is not a prerequisite [129]. There is a concern of off-target cleav-
age activity from the endonuclease from CRISPR/Cas9 because the system requires 
recognition of only 20 bp target sequence and allows up to 5 bp mismatches for the 
formation of DSB [124]. Several strategies for minimizing the off-target cleavage have 
been employed including use of double nickase mutant form of Cas9, which induces 
a single-strand break instead of DSB [130]; use of Cas9-sgRNA ribonucleoprotein 
(RNP) complex, whose half-life is shorter than that the time in which plasmid or viral 
nucleic acid is transcribed [131]; or use of fusions of catalytically inactive Cas9 with 
Fok I nuclease domain (fCas9) to improve the DNA cleavage specificity [132].
In the case of producing GM animals using SMGT or TMGT, it is better for the 
exogenous DNA (transgenes) to be integrated into the chromosomes of sperm. This 
event appears to occur more frequently in immature sperm cells present in the ST 
of a testis than in the mature epididymal sperm because the chromosomal DNA in 
the latter cells is tightly packed in the head region of a sperm. In this context, STGT 
is a preferable system to create GM animals because it is targeted to transfection 
of spermatogenic cells present within the STs. However, it takes about 4 weeks 
for mature sperm to reach the epididymal portion for fertilization. If a researcher 
wants to generate GM animals within a short period of time, direct transfection 
of mature sperm present in epididymides or vas deferens is recommended. In this 
case, as mentioned above, the introduced exogenous DNA may be associated to 
the extracellular fraction of a sperm, as episomal DNA. Notably, CRISPR/Cas9-
based genome editing does not always require chromosomal integration of its 
components; it can be performed by transient expression of their components after 
transfection [129]. In this sense, an attempt to transfect mature sperm would be a 
useful alternative for GM animal production.
6.  Proposal of new experimental systems for simple creation of  
genome-edited animals using in vivo or in vitro transfected sperm
In the following section, we propose two experimental plans to create genome-
edited animals using VDGT or AI-based systems, all of which are simpler and more 
convenient than the previously described systems.
ZFN TALEN CRISPR/
Cas9
Working 
mechanism
DNA/protein interaction DNA/RNA/protein interaction DNA/RNA/
protein 
interaction
Core 
components
TALE and Fok I fusion 
protein
TALE and Fok I fusion protein Cas9 protein 
and sgRNA
Design Easy Easy Very easy
Construction Easy Easy Very easy
Efficiency High High High
Off-target rate Low High High
1Based on Chen and Gao [126].
Table 2. 
Comparison of ZFN, TALEN, and CRISPR/Cas9-mediated genome editing systems1.
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6.1 VDGT-based genome editing
As previously described in Section 2.4, VDGT enables transfer of exogenous DNA 
to oocytes via fertilization by mature sperm transfected within vas deferens [87, 88]. 
Injecting a solution containing genome editing components (e.g., sgRNA + DNA/
mRNA/protein for Cas9) into the lumen of vas deferens of anesthetized males and 
subsequent mating between the VDGT-treated males and normal estrous females the 
day (night) after the surgery may result in production of genome-edited offspring.
In Figure 6a–c, experiments obtained after TB injection into the lumen of mouse 
vas deferens is shown (unpublished results). Under anesthesia, cauda epididymis 
and vas deferens were pulled out and a small slit was made at the proximal region of 
vas deferens using micro scissors (Figure 6a). Then, a glass micropipette containing 
TB was inserted into the lumen of vas deferens under observation using a dissecting 
microscope and about 15 μL of the solution is slowly injected (Figure 6b). It is easily 
discernible that the injected TB still remains within the proximal portion of vas  
deferens immediately after the injection (arrows in Figure 6c). However, the 
injected TB moved to the distal portion of vas deferens the next day (arrow in  
Figure 6d). Thus, to produce genome-edited animals by VDGT, a solution contain-
ing CRISPR/Cas9 components (sgRNA + DNA/mRNA/protein for Cas9), gene 
delivery enhancing reagents (such as DMSO, liposomes, microparticles, etc.) and 
fluorescent marker expression plasmid DNA has to be prepared first (Figure 6e). 
Figure 6. 
Procedure for VDGT-based genome editing. (a–d) Experimental procedure of VDGT when TB as a visible 
marker is injected into the lumen of vas deferens. Under anesthesia, a small slit is made at the proximal region of 
vas deferens using micro scissors (a). Then, a glass micropipette is inserted into the lumen of vas deferens under 
observation using a dissecting microscope and the solution is slowly injected (b). After TB injection, the injected 
TB still remains within the proximal portion of vas deferens (arrows in c). One day after VDGT, the injected TB 
moves to the distal portion of vas deferens (arrow in d), showing the flow of the injected substance. e. Experimental 
procedure of VDGT when genome-editing components are injected into the lumen of vas deferens. First, a solution 
containing CRISPR/Cas9 components, gene delivery enhancing reagents (such as DMSO, liposomes, microparticles, 
etc.), and fluorescent marker expression plasmid DNA is prepared in a tube. Then, about 15 μL of this solution 
is immediately injected into the lumen of vas deferens. On the night following the VDGT or the next day, the 
VDGT-treated males are mated to normal estrous females. Later, cleavage stage embryos are collected to examine 
the presence/expression of the transgene (plasmid), as well as possible mutations in a target locus.
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After short incubation period, this solution is injected into the lumen of vas defer-
ens. Then, the VDGT-treated males are mated to normal estrous females on the day 
(night) or next day. Later, cleavage stage embryos were collected from the VDGT-
treated females to examine the presence and expression of the transgene (plasmid) 
(Figure 6e, bottom) and occurrence of mutations in a target locus. In some cases, 
the SMGT-AI-treated females were allowed to deliver their pups to see whether 
genome editing is induced in their chromosomes.
6.2 SMGT-AI-based genome editing
AI is one of the assisted reproduction technologies that is based on the introduc-
tion of isolated sperm into the female reproductive tracts, such as uterine horn or 
oviductal lumen, to in vivo fertilize ovulated oocytes. As previously described in 
Section 3, isolated sperm are incubated in a solution containing exogenous DNA 
and gene delivery enhancing reagents such as DMSO, liposomes, and micropar-
ticles, for a short period (SMGT), and then the transfected sperm are subjected to 
AI, called “SMGT-based AI” (SMGT-AI). During this process, the exogenous DNA 
should be transmitted to oocytes via fertilization resulting in Tg embryos.
We previously reported that transfer of sperm into a space near the infun-
dibulum between the ovary and ovarian bursa enables in vivo fertilization of 
ovulated oocytes in the ampulla region of the oviduct [133, 134]. In more detail, 
2 μL of fresh epididymal B6C3F1 (F1 hybrid mice between C57BL/6 and C3H) 
sperm (containing 2 x 105 spermatozoa) were intrabursally injected 7 h after 
human chorionic gonadotropin (hCG) administration to B6C3F1 females that 
had been administrated with pregnant mare serum gonadotropin (PMSG) 48 h 
before. At 1.7 days after AI, normal cleaving embryos were recovered at rates of 
40–100%. We called this AI technology “intrabursal transfer of sperm” (ITS) 
[133]. In Figure 7a, the ITS procedure is schematically illustrated. In Figure 7b 
and c, photographs before (b) and after (c) ITS are shown by using TB as a dye to 
visualize the process of AI. It is clear that the injected solution is present between 
the ovary and ovarian bursa (arrow in Figure 7c). In Figure 7d, an example for 
SGMT-AI-mediated genome editing in embryos is schematically shown. First, 
sperm isolated from the vas deferens are treated with CRISPR/Cas9 components 
(sgRNA + DNA/mRNA/protein for Cas9), gene delivery enhancing reagents (such 
as DMSO, liposomes, microparticles, etc.), and fluorescent marker expression 
plasmid DNA for a short period. Then, the solution containing the transfected 
sperm is subjected to AI towards females 7 h after hCG administration. The next 
day, 2-cell embryos are collected from the AI-treated females to examine the pres-
ence and expression of the transgene (plasmid) and occurrence of mutations in 
a target locus. In some cases, the SMGT-AI-treated females are allowed to deliver 
their pups to see whether genome editing is induced in their chromosomes. 
Notably, the selection of a successfully genome-edited sperm prior to AI may 
accelerate the production efficiency of genome edited offspring, although the 
practical approach for this remains unknown at present. Therefore, the success or 
failure of genome editing performed in this system may depend on the molecular 
analysis of the offspring (e.g. blastocysts or fetuses) generated after AI of the 
SMGT-treated sperm.
7. Conclusion
TMGT, based on direct in vivo gene delivery towards interstitial space of a testis, 
ST within a testis, or excurrent ducts of epididymides and vas deferens, is less labor 
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intensive and less time consuming for the production of GM animals. This testicular 
route is also ethically superior since fewer mice are required than existing alterna-
tive methods of transgenesis. The TMGT-treated males can be used to mate with 
estrous females, through which the exogenous genetic materials are transferred to 
oocytes at fertilization. During this process, there is no need for ex vivo handling 
of embryos, which is strictly required for zygote-based gene modification such as 
microinjection, EP, viral infection, and TransICSI. SMGT-AI, based on AI of sperm 
that have been transfected in vitro with the exogenous DNA, is also a convenient 
system for production of Tg animals, like TMGT. The CRISPR/Cas9 system, one 
of the recently developed genome editing technologies, is now recognized as a 
powerful and simple tool to create GM animals. More importantly, in this system, 
chromosomal integration of the genome editing components is not the prerequisite. 
Coupling this genome editing system with TMGT or SMGT-AI would accelerate 
creation of genome-edited animals in a more convenient manner. Furthermore, 
TMGT/SMGT-AI will be particularly useful for other animals that are difficult to 
manipulate as early embryos in vitro.
Figure 7. 
Procedure for SMGT-AI-based genome editing. (a) ITS procedure schematic. (b, c) Photographs during 
before (b) and after (c) ITS, which is shown by intrabursal injection of TB. Note the presence of TB between 
the ovary and ovarian bursa (arrow in c). (d) Experimental procedure of SMGT-AI when genome-editing 
components are injected between the ovary and ovarian bursa. First, sperm isolated from the vas deferens 
are incubated in a solution containing CRISPR/Cas9 components, gene delivery enhancing reagents (such 
as DMSO, liposomes, microparticles, etc.) and fluorescent marker expression plasmid DNA for a short 
period. Then, the solution containing the transfected sperm is subjected to AI towards females 7 h after hCG 
administration. Later, cleavage stage embryos are collected to examine the presence/expression of the transgene 
(plasmid), as well as possible mutations in a target locus.
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